Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

被引:167
作者
Alexandre, Francois-Rene [1 ]
Amador, Agnes [1 ]
Bot, Stephanie [1 ]
Caillet, Catherine [1 ]
Convard, Thierry [1 ]
Jakubik, Jocelyn [3 ]
Musiu, Chiara [2 ]
Poddesu, Barbara [2 ]
Vargiu, Luana [2 ]
Liuzzi, Michel [2 ]
Roland, Arlene [1 ]
Seifer, Maria [3 ]
Standring, David [3 ]
Storer, Richard [1 ]
Dousson, Cyril B. [1 ]
机构
[1] Labs Idenix, Dept Chim Med, F-34189 Montpellier 4, France
[2] Univ Cagliari, Cooperat Lab Idenix, Zona Ind Macchiareddu UTA, Idenix Pharmaceut, I-09010 Cagliari, Italy
[3] Idenix Pharmaceut, Cambridge, MA 02139 USA
关键词
ANALOGS; DESIGN; POTENT;
D O I
10.1021/jm101142k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of 3-aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 was developed Chemical variation in the phosphorus linker led to the discovery of 3-phenyl-methyl-phosphinate-2-carboxamide 14, which possessed excellent potency against wild-type HIV-1 as well as viruses bearing K103N and Y181C single mutants in the reverse transcriptase gene Chiral separation of the enantiomers showed that only R enantiomer retained the activity The pharmacokinetic, solubility, and metabolic properties of 14 were assessed
引用
收藏
页码:392 / 395
页数:4
相关论文
共 20 条
[1]   PREPARATION AND REACTIONS OF 1-(TERT-BUTYLDIMETHYLSILYL)-3-LITHIOINDOLE, REGIOSELECTIVE SYNTHESIS OF 3-SUBSTITUTED INDOLES [J].
AMAT, M ;
HADIDA, S ;
SATHYANARAYANA, S ;
BOSCH, J .
JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (01) :10-11
[2]  
[Anonymous], 2006, WO PCT Int. Appl., Patent No. 054182
[3]   Non-nudeoside reverse transcriptase inhibitors - an overview [J].
Bell, C ;
Matthews, GV ;
Nelson, MR .
INTERNATIONAL JOURNAL OF STD & AIDS, 2003, 14 (02) :71-77
[4]   Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants [J].
Das, K ;
Clark, AD ;
Lewi, PJ ;
Heeres, J ;
de Jonge, MR ;
Koymans, LMH ;
Vinkers, HM ;
Daeyaert, F ;
Ludovici, DW ;
Kukla, MJ ;
De Corte, B ;
Kavash, RW ;
Ho, CY ;
Ye, H ;
Lichtenstein, MA ;
Andries, K ;
Pauwels, R ;
de Béthune, MP ;
Boyer, PL ;
Clark, P ;
Hughes, SH ;
Janssen, PAJ ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2550-2560
[5]   From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125):: Fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase [J].
De Corte, BL .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) :1689-1696
[6]   SYNTHESIS AND NMR SPECTROSCOPIC INVESTIGATION OF PHENYLPHOSPHORYL DERIVATIVES [J].
DUDDECK, H ;
LECHT, R .
PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 1987, 29 (2-4) :169-178
[8]   Synthesis and antiviral evaluation of thieno[3,4-d] pyrimidine C-nucleoside analogues of 2′,3′-dideoxy- and 2′,3′-dideoxy-2′,3′-didehydro-adenosine and -inosine [J].
Hamann, Marie ;
Pierra, Claire ;
Sommadossi, Jean-Pierre ;
Musiu, Chiara ;
Vargiu, Luana ;
Liuzzi, Michel ;
Storer, Richard ;
Gosselin, Gilles .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (06) :2321-2326
[9]   Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1. [J].
Hopkins, AL ;
Ren, JS ;
Milton, J ;
Hazen, RJ ;
Chan, JH ;
Stuart, DI ;
Stammers, DK .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) :5912-5922
[10]   Novel HIV-1 reverse transcriptase inhibitors [J].
Jochmans, Dirk .
VIRUS RESEARCH, 2008, 134 (1-2) :171-185